Previous studies suggest that antagonism of GHSR signaling could ameliorate obesity by reducing food intake and promoting weight loss, as GHSR-null mice exhibited reduced fat deposition and increased energy expenditure, showing resistance to DIO [74]. Here, GHSR is linked to obesity due to melanocortin 4 receptor deficiency.